Cancer Risk
Cancer Risk
Download on App Store

This page is not an official page of the app or its developer, but an independent editorial publication created for informational and commentary purposes. Unless expressly stated otherwise, neither the app nor its developer is affiliated with, endorsed by, sponsored by, authorized by, or otherwise officially connected with MWM, Apple, Google Play, the app publisher, or the app's developer, and nothing on this page implies that the app was developed using MWM's services. Any trademarks, logos, screenshots, and other content remain the property of their respective owners.

Logo of Cancer Risk
Download on App Store

Cancer Risk

Gain clarity on your PSA results with data from the world's largest prostate cancer screening study. Empower yourself with evidence-based insights to make informed decisions about biopsies and your long-term health.

Key Figures

Downloads

143K+

User Rating

1.0/5

Total Ratings

0

Publisher

Stichting SWOP

Category

Medical

Locales

9

Latest Version

3.6

Size

6.0 MB

First Released

Oct 25, 2013
Features

Empower Your Health Decisions

The Rotterdam Prostate Cancer Risk Calculator provides a scientifically-validated assessment to help you and your doctor move beyond a single PSA test result.

Evidence-Based Accuracy

Leverage data from the ERSPC, the world’s largest randomized screening study, to get risk calculations backed by peer-reviewed medical research.

Comprehensive Risk Profile

Go beyond the PSA number by integrating multiple clinical factors to better understand your actual risk level and avoid unnecessary anxiety.

The following screenshots and description are sourced directly from the app's official store listing and are the property of the app developer.

App Store

Screenshots

Cancer Risk - Prostate cancer risk calculator screen asking for MRI information.

Prostate cancer risk calculator screen asking for MRI information.

Cancer Risk - Interface of the Rotterdam Prostate Cancer Risk Calculator app showing input fields for PSA levels and medical history

Interface of the Rotterdam Prostate Cancer Risk Calculator app showing input fields for PSA levels and medical history

Cancer Risk - The final results screen of the Cancer Risk app displaying percentages for detectable and significant cancer risk.

The final results screen of the Cancer Risk app displaying percentages for detectable and significant cancer risk.

Cancer Risk - About screen of the Cancer Risk app explaining the medical research and foundation behind the prostate cancer risk calculator

About screen of the Cancer Risk app explaining the medical research and foundation behind the prostate cancer risk calculator

Cancer Risk - Language selection screen in the Cancer Risk app with multiple language options listed.

Language selection screen in the Cancer Risk app with multiple language options listed.

Description

The Rotterdam Prostate Cancer Risk Calculator is based on ERSPC, Rotterdam, data and supported by the Prostate Cancer Research Foundation, Rotterdam (SWOP)     The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract. Please be aware that the Rotterdam Prostate Cancer Risk Calculator for iOS cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis. The Rotterdam Prostate Cancer Risk Calculator for iOS provides a general risk calculation based on your PSA level and other information. While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor. It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low. Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator. It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for iOS is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for iOS do not accept any responsibility in any respect. The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%. ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group. Designed and developed for iOS by Nuno Azevedo of Ydeal.net Software LDA

Download

Download on App Store

This page is not an official page of the app or its developer, but an independent editorial publication created for informational and commentary purposes. Unless expressly stated otherwise, neither the app nor its developer is affiliated with, endorsed by, sponsored by, authorized by, or otherwise officially connected with MWM, Apple, Google Play, the app publisher, or the app's developer, and nothing on this page implies that the app was developed using MWM's services. Any trademarks, logos, screenshots, and other content remain the property of their respective owners.